News

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection

Gimv is increasing its commitment to AgroSavfe, an innovative food and agro-biotech company developing environmentally friendly plant protection products. As co-founder and lead investor, Gimv participates in a Series C financing round of EUR 35 million, in which Ackermans & van Haaren joins as a new investor, in addition to the existing shareholders who also […]

Continue Reading
Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software

Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software

Gimv, together with all other shareholders, is selling its stake in Stuttgart-based software firm thinkstep AG (www.thinkstep.com) to US software provider Sphera Solutions. Thanks to the long-term support of all investors, thinkstep has grown substantially and successfully transformed its business model into a software-as-a-service solution (SaaS). Headquartered in Leinfelden-Echterdingen near Stuttgart, thinkstep was founded in […]

Continue Reading
Gimv exits Legallais, ironmongery distributor for building professionals in France

Gimv exits Legallais, ironmongery distributor for building professionals in France

Gimv announced its exit from French company Groupe Legallais, in which it has held a minority stake since February 2016. Founded in 1889, Legallais is a leading independent distributor of ironmongery and finishing work products for building professionals. Legallais (www.legallais.com) was established in 1889 and grew into the reference in the French market when it […]

Continue Reading
Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

Today, Gimv, Sofinnova and Gilde Healthcare announced the sale of biopharmaceutical company Breath Therapeutics. Specialising in advanced and first-in-class inhalation therapies for severe respiratory diseases, Breath Therapeutics collected around EUR 43.5 million in one of the largest start-up financing rounds in 2017. With the support of the investors, two global Phase III trials are currently […]

Continue Reading

Standard Investment neemt belang in staalbouwbedrijf Hollandia

Standard Investment heeft in mei van dit jaar 50% van de aandelen in bedrijfsonderdelen Hollandia Structures, Hollandia Infra, Hollandia Services, Everest Industriële Montage en Hollandia UK (samen Hollandia Orange) overgenomen van Hollandia Holding, een van de meest toonaangevende Nederlandse bedrijven op het gebied van staal- en werktuigbouw. Hollandia heeft in haar 90-jarige bestaan binnen en […]

Continue Reading
DMC Biotechnologies announces first close of US$10.3M Series A financing led by Sofinnova Partners

DMC Biotechnologies announces first close of US$10.3M Series A financing led by Sofinnova Partners

Boulder, CO, USA:  9 July 2019 – DMC, an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition to its Board of Directors of Josko Bobanovic, Partner and Manager of the Sofinnova Industrial Biotech Fund. Current investors Capricorn Venture Partners […]

Continue Reading
First closing of Capricorn Digital Growth Fund at € 48 million

First closing of Capricorn Digital Growth Fund at € 48 million

Leuven, Belgium: 28 June 2019 – Capricorn Venture Partners, the Leuven-based independent manager of venture capital and equity funds, announces the first closing of its latest initiative, the Capricorn Digital Growth Fund securing more than € 48 million of commitments. Key investors in this first closing are Quest for Growth, PMV (ParticipatieMaatschappij Vlaanderen), FPIM (Federale Participatie […]

Continue Reading
Amaya and Laure de Gorostarzu partner with Vendis Capital to support the development of L’Atelier d’Amaya.

Amaya and Laure de Gorostarzu partner with Vendis Capital to support the development of L’Atelier d’Amaya.

Brussels, 3 June 2019 – Vendis Capital, the private equity fund specialized in consumer brands, joins forces with Laure and Amaya de Gorostarzu, co-founders of the jewellery brand L’Atelier d’Amaya.   Bordeaux-based L’Atelier d’Amaya designs and markets an extensive range of silver and golden jewellery, combining timeless products with trendy creations and allowing customers to […]

Continue Reading